? Prophylactic Quadrivalent Human Papillomavirus (Types 6,11,16 and 18) L1 Virus-Like Particle Vaccine in Young Women: a randomized, double-blind, placebo-controlled multicentre phase II efficacy trial.? Lancet Oncol, 6(5):271-278, 2005.
VILLA, L.L., COSTA, R.L.R., PETTA, C. A., ANDRADE RP., AULT K.A., GIULIANO A.R., WHEELER C.M., KOUTSKY L.A., MALM C., LEHTINEN M., SKJELDESTAD F.E., OLSSON, S-E., STEINWALL, M., BROWN, D.R., KURMAN R.J., RONNETT, B.M., STOLER, M.H., FERENCZY, A., HARPE